These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2503562)

  • 1. Quantitation of the anaphylatoxin C3a in the presence of C3 by a novel sandwich ELISA using monoclonal antibody to a C3a neoepitope.
    Zilow G; Naser W; Rutz R; Burger R
    J Immunol Methods; 1989 Jul; 121(2):261-8. PubMed ID: 2503562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The C terminus of the anaphylatoxin C3a generated upon complement activation represents a neoantigenic determinant with diagnostic potential.
    Burger R; Zilow G; Bader A; Friedlein A; Naser W
    J Immunol; 1988 Jul; 141(2):553-8. PubMed ID: 2454995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A modified competitive inhibition radioimmunoassay for the detection of C3a. Use of 125I-C3 instead of 125I-C3a.
    Hack CE; Paardekooper J; Eerenberg AJ; Navis GO; Nijsten MW; Thijs LG; Nuijens JH
    J Immunol Methods; 1988 Apr; 108(1-2):77-84. PubMed ID: 3258341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitation of C3a by ELISA using a monoclonal antibody to a neoantigenic C3a determinant.
    Zilow G; Naser W; Friedlein A; Bader A; Burger R
    Prog Clin Biol Res; 1989; 308():299-304. PubMed ID: 2476822
    [No Abstract]   [Full Text] [Related]  

  • 5. A simplified assay for the detection of C3a in human plasma employing a monoclonal antibody raised against denatured C3.
    Nilsson B; Svensson KE; Inganäs M; Nilsson UR
    J Immunol Methods; 1988 Mar; 107(2):281-7. PubMed ID: 3257998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional analysis and quantification of the complement C3 derived anaphylatoxin C3a with a monoclonal antibody.
    Burger R; Bader A; Kirschfink M; Rother U; Schrod L; Wörner I; Zilow G
    Clin Exp Immunol; 1987 Jun; 68(3):703-11. PubMed ID: 3498585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of native human complement components C3 and C5 and their primary activation peptides C3a and C5a (anaphylatoxic peptides) by ELISAs with monoclonal antibodies.
    Klos A; Ihrig V; Messner M; Grabbe J; Bitter-Suermann D
    J Immunol Methods; 1988 Jul; 111(2):241-52. PubMed ID: 3260926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A sensitive enzyme immunoassay for the quantitation of human C5a/C5a(desArg) anaphylatoxin using a monoclonal antibody with specificity for a neoepitope.
    Oppermann M; Schulze M; Götze O
    Complement Inflamm; 1991; 8(1):13-24. PubMed ID: 1710957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement activation in newborn infants with early onset infection.
    Zilow G; Zilow EP; Burger R; Linderkamp O
    Pediatr Res; 1993 Aug; 34(2):199-203. PubMed ID: 8233725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement anaphylatoxins in idiopathic mixed cryoglobulinemia.
    Miadonna A; Leggieri E; Tedeschi A; Cottini M; Invernizzi F; Froldi M; Zanussi C
    Int Arch Allergy Appl Immunol; 1985; 76(2):120-5. PubMed ID: 3967939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ELISA of complement C3a in bronchoalveolar lavage fluid.
    van de Graaf EA; Jansen HM; Bakker MM; Alberts C; Eeftinck Schattenkerk JK; Out TA
    J Immunol Methods; 1992 Mar; 147(2):241-50. PubMed ID: 1548406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification in enzyme-linked immunosorbent assay of a C3 neoepitope expressed on activated human complement factor C3.
    Garred P; Mollnes TE; Lea T
    Scand J Immunol; 1988 Mar; 27(3):329-35. PubMed ID: 2451274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement activation in patients with isolated antiphospholipid antibodies or primary antiphospholipid syndrome.
    Breen KA; Seed P; Parmar K; Moore GW; Stuart-Smith SE; Hunt BJ
    Thromb Haemost; 2012 Mar; 107(3):423-9. PubMed ID: 22234447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C3a(desArg) does not bind to and signal through the human C3a receptor.
    Wilken HC; Götze O; Werfel T; Zwirner J
    Immunol Lett; 1999 Apr; 67(2):141-5. PubMed ID: 10232396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The human mast cell line HMC-1 binds and responds to C3a but not C3a(desArg).
    Zwirner J; Götze O; Sieber A; Kapp A; Begemann G; Zuberbier T; Werfel T
    Scand J Immunol; 1998 Jan; 47(1):19-24. PubMed ID: 9467653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel monoclonal antibodies against mouse C3 interfering with complement activation: description of fine specificity and applications to various immunoassays.
    Mastellos D; Prechl J; László G; Papp K; Oláh E; Argyropoulos E; Franchini S; Tudoran R; Markiewski M; Lambris JD; Erdei A
    Mol Immunol; 2004 Mar; 40(16):1213-21. PubMed ID: 15104126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantification of Porcine Complement Activation Fragment C3a by a Neoepitope-Based Enzyme-Linked Immunosorbent Assay.
    Nilsson PH; Pettersen K; Oppermann M; Skjeflo EW; Fure H; Christiansen D; Mollnes TE
    Methods Mol Biol; 2021; 2227():51-59. PubMed ID: 33847930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement activation products in liquid stored plasma and C3a kinetics after transfusion of autologous plasma.
    Norda R; Schött U; Berséus O; Akerblom O; Nilsson B; Ekdahl KN; Stegmayr BG; Knutson F
    Vox Sang; 2012 Feb; 102(2):125-33. PubMed ID: 21770955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased serum levels of complement C3a anaphylatoxin indicate the presence of colorectal tumors.
    Habermann JK; Roblick UJ; Luke BT; Prieto DA; Finlay WJ; Podust VN; Roman JM; Oevermann E; Schiedeck T; Homann N; Duchrow M; Conrads TP; Veenstra TD; Burt SK; Bruch HP; Auer G; Ried T
    Gastroenterology; 2006 Oct; 131(4):1020-9; quiz 1284. PubMed ID: 17030172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a simple radioimmunoassay for human C3a.
    Lamche HR; Paul E; Schlag G; Redl H; Hammerschmidt DE
    Inflammation; 1988 Jun; 12(3):265-76. PubMed ID: 3262087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.